Abstract: An approach to the synthesis of 7-methyl-4-azaindole, which is a valuable building block for drug discovery programs, is described. The method relies on using a bromine atom as a 'place holding group' for one of the carbon atoms of the pyridine ring throughout the reaction sequence, and it is removed only upon the final reductive cyclization leading to the azaindole ring. Exhaustive hydrogenation of the target product proceeds in a diastereoselective manner and leads to a bicyclic conformationally restricted diamine derivative.
Introduction
In medicinal chemistry, building an effective structureactivity relationship (SAR) study requires the possibility of introducing substituents into every position of the molecule identified as an initial hit [1] . Even the smallest structural modification, such as a methyl group, can sometimes dramatically influence the biological properties of the compound when placed in a proper site of the molecular scaffold [2] . Pyrrolopyridines ('azaindoles') are scaffolds which have been widely used in drug discovery; the recently registered anti-cancer drugs venetoclax (1) and vemurafenib (2) [3] , an anti-HIV agent BMS-378806 (3) [4] , an anti-mycobacterial compound 4 [5] and a potential agent for the treatment of the cognitive impairments 5 [6] can be mentioned among the most prominent examples (Figure 1 ).
While the synthesis of various substituted azaindoles is generally well documented, some of the regioisomeric derivatives remain hardly accessible, in particular, 7-methyl-4-azaindole (6), a building block which was needed for our project on azaindole derivatives in multigram quantities. It was involved in the design of M 1 receptor positive allosteric modulators [6] , muscarinic acetylcholine receptor modulators [7] , decaprenylphosphoryl-β-D-ribose-2′-epimerase (DprE1) inhibitors [8] or HIV-1 attachment inhibitors [9] . However, all preparations of 6 reported so far (Scheme 1) were inefficient for the multigram preparation due to a dramatic yield drop at the key steps of Bartoli cyclization [10] and sp 2 -sp 3 Suzuki coupling [8] ) upon scale-up. In this work, we report an efficient method for the multigram synthesis of 6, which in our opinion may also be useful for the preparation of other 7-substituted 4-azaindole derivatives.
Results and discussion
Our approach to the synthesis of compound 6 relied on the known reductive cyclization of 2-(3-nitropyridin-2-yl) acetonitriles of general formula 7 (Scheme 2) [11] [12] [13] . To the best of our knowledge, this method was not used for the preparation of 7-substituted 4-azaindole derivatives previously. The initial retrosynthetic approach to 6, according to the selected strategy, led us to compound 8. As there was no obvious way to assemble this 2,3,4-trisubstituted pyridine or any relevant synthetic precursor in a scalable manner (e.g., the related known compound 9 [14] is obtained via non-chemoselective nitration of amine 10), we switched to the tetrasubstituted derivative 11 as a possible synthetic equivalent of 8. The bromine atom was introduced into the molecule of 11 as a 'place holding group' for the sterically accessible C-5 position of the pyridine ring, which might be removed upon reductive conditions of the last step.
Our synthesis of compound 11 commenced from 2-amino-4-methylpyridine (10), which is readily available from commercial sources on a kilogram scale (Scheme 3). Compound 10 was transformed into 2,3,4,5-tetrasubstituted pyridine 12 using reported procedures [15] [16] [17] . Diazotation of 12 in the presence of HBr and Br 2 gave dibromide 13 (65%), which was purified by crystallization from hexanes. Reaction of 13 with tert-butyl cyanoacetate proceeded in a regioselective manner and the product 14 was isolated in a 49% yield. It should be noted that 14 existed in equilibrium with its tautomer 14′. Acidic hydrolysis of 14 was accompanied by decarboxylation and led to the target compound 11 in an excellent yield of 92%. The key step of the synthesis -reductive cyclization of 11 -proceeded smoothly using inexpensive and common 10% Pd-C as a catalyst. As expected, heterocyclization was accompanied by debromination and gave the target 4-azaindole 6 in a good yield of 84%. Notably, the reaction sequence described above allowed the preparation of up to 30 g of 6 in a single run. In our opinion, the developed method allows the preparation of even larger quantities of the target compound. Some transformations were performed with azaindole 6 to demonstrate its chemical properties and potential for functionalization (Scheme 4). A partial reduction of the bicyclic system was achieved by treatment with BH 3 · Me 2 S, which furnished 2,3-dihydro-1H-pyrrolo [3,2-b] pyridine derivative 15 in a 71% yield. Further reduction of the pyridine ring was performed by catalytic hydrogenation; it occurred in a diastereoselective manner and gave (3aR*,7R*,7aR*)-isomer 16 in a 76% yield, which was isolated as a sulfate salt. The relative stereochemistry of 16 · H 2 SO 4 was established using the nuclear Overhauser effect spectroscopy (NOESY) experiment ( Figure 2 ). It should be noted that direct hydrogenation of 6 to 16 was not successful. Compound 16 is a representative of bicyclic conformationally restricted diamines which are valuable building blocks in medicinal chemistry [18] . Finally, formylation of 6 with urotropine in aqueous AcOH gave 3-formyl derivative 17 in a 62% yield.
Conclusions
A convenient and scalable approach to 7-methyl-4-azaindole was developed. The method relies on using a bromine atom as a 'place holding group' for one of the carbon atoms of the pyridine ring throughout the reaction sequence, which is removed only upon the final reductive cyclization. The described reaction sequence can also be used for the synthesis of other substituted 4-azaindoles.
Experimental
The solvents were purified according to the standard procedures [19] . Compound 12 was prepared in a 85% yield from 10 using a reported method [15] [16] [17] . All other starting materials were purchased from commercial sources. Analytical thin-layer chromatography was performed using Polychrom SI F254 plates. Column chromatography was performed using Kieselgel Merck 60 (230-400 mesh) as the stationary phase. 
2,5-Dibromo-4-methyl-3-nitropyridine (13)
Aqueous HBr (47%, 195 mL) and Br 2 (186 g, 1.17 mol, 60 mL) were added to compound 12 (90.0 g, 0.39 mol). A saturated solution of NaNO 2 (69.0 g, 1.00 mol) was added slowly to the mixture under mechanical stirring at 0-5°C. The mixture was stirred at 15°C for 2 h and then diluted with H 2 O (1.5 L). The precipitate was filtered, washed with H 2 O and dissolved in CHCl 3 (500 mL). The solution was washed with 15% aqueous NaHSO 3 ( 
tert-Butyl 2-(5-bromo-4-methyl-3-nitropyridin-2-yl)-2-cyanoacetate (14)
To a solution of tert-butyl cyanoacetate (33.8 g, 0.24 mol) in DMF (310 mL), K 2 CO 3 (63.6 g, 0.46 mol) was added, followed by portion-wise 
2-(5-Bromo-4-methyl-3-nitropyridin-2-yl)acetonitrile (11)
To a solution of compound 14 (25.0 g, 70.2 mmol) in MeCN (500 mL), an aqueous solution of HCl (17%, 250 mL) was added. The mixture was heated under reflux for 2 h, then cooled and concentrated under reduced pressure. The residue was taken up in an aqueous saturated solution of NaHCO 3 (250 mL), and the product was extracted with EtOAc (4 × 300 mL). The extract was dried over MgSO 4 and concentrated under reduced pressure. The crude product was purified by silica gel flash chromatography eluting with hexanes/EtOAc (1:1) 
7-Methyl-1H-pyrrolo[3,2-b]pyridine (6)
A mixture of compound 11 (14.0 g, 54.7 mmol) and 10% Pd/C (8.0 g) in aqueous 96% EtOH (400 mL) was hydrogenated under 50 bar of H 2 at room temperature for 30 h. The catalyst was filtered and the filtrate was concentrated under reduced pressure. Aqueous saturated NaHCO 3 was added to the residue to adjust to pH 8, and the mixture was concentrated. The residue was treated with hot i-PrOH (400 mL) filtered, and the filtrate was concentrated under reduced pressure. 
7-Methyl-2,3-dihydro-1H-pyrrolo[3,2-b]pyridine (15)
To a stirred solution of compound 6 (1.98 g, 15.0 mmol) in dry THF (100 mL), BH 3 · Me 2 S (16.0 g, 12.8 mL, 210 mmol) was added, and the mixture was heated under reflux for 11 h. After cooling, MeOH (25 mL) was added dropwise and the mixture was concentrated. MeOH (150 mL) and concentrated aqueous HCl (20 mL) were added to the residue. The mixture was stirred under reflux for 6 h, then cooled and concentrated under reduced pressure. An aqueous solution of NaOH (20%, 50 mL) was added to the residue, and the product was extracted with Et 2 O (4 × 15 mL). The organic layers were combined, dried over Na 2 SO 4 and concentrated under reduced pressure. The crude product was purified by silica gel column chromatography eluting with CHCl 3 /MeOH (9:1); yield 1.43 g (71%) of white solid; mp 97-99°C; A mixture of compound 15 (1.00 g, 7.50 mmol), 10% Pd(OH) 2 -C (1.00 g), MeOH (50 mL) and concentrated aqueous HCl (1.5 mL) was hydrogenated at 35 bar of H 2 at 60°C for 24 h. The catalyst was filtered and the filtrate was concentrated under reduced pressure. An aqueous solution of NaOH (10%, 15 mL) was added to the residue, and the product was extracted with Et 2 O (4 × 30 mL). The combined organic extracts were dried over Na 2 SO 4 and concentrated under reduced pressure. The crude product was dissolved in aqueous 96% EtOH (30 mL) and the solution was treated with concentrated H 2 SO 4 to adjust to pH 4. The resultant diamine sulfate was filtered and crystallized from aqueous 96% EtOH (120 mL); yield 
7-Methyl-1H-pyrrolo[3,2-b]pyridine-3-carbaldehyde (17)
A mixture of compound 6 (3.00 g, 22.7 mmol) and hexamethylenetetramine (4.91 g, 35.0 mmol) in a mixture of acetic acid (20 mL) and H 2 O (50 mL) was heated under reflux for 6 h, then cooled and concentrated under reduced pressure. A saturated aqueous solution of NaHCO 3 (50 mL) was added to the residue, and the product was extracted with EtOAc (4 × 50 mL). The organic layers were combined, dried over Na 2 SO 4 and concentrated under reduced pressure. The crude product was purified by silica gel column chromatography eluting with CHCl 3 /MeOH (4:1); yield 2.25 g (62%) of light yellow solid; mp 210-212°C; 
